Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Callen Moreu Website

Elsa Callen Moreu, Ph.D.

Selected Publications
1)  Barlow JH, Faryabi RB, Callén E, Wong N, Malhowski A, Chen HT, Gutierrez-Cruz G, Sun HW, McKinnon P, Wright G, Casellas R, Robbiani DF, Staudt L, Fernandez-Capetillo O, Nussenzweig A.
Identification of early replicating fragile sites that contribute to genome instability.
Cell. 152: 620-32, 2013. [Journal]
2)  Di Virgilio M, Callen E, Yamane A, Zhang W, Jankovic M, Gitlin AD, Feldhahn N, Resch W, Oliveira TY, Chait BT, Nussenzweig A, Casellas R, Robbiani DF, Nussenzweig MC.
Rif1 prevents resection of DNA breaks and promotes immunoglobulin class switching.
Science. 339: 711-5, 2013. [Journal]
3)  Callen E, Faryabi RB, Luckey M, Hao B, Daniel JA, Yang W, Sun HW, Dressler G, Peng W, Chi H, Ge K, Krangel MS, Park JH, Nussenzweig A.
The DNA damage- and transcription-associated protein paxip1 controls thymocyte development and emigration.
Immunity. 37: 971-85, 2012. [Journal]
4)  Feldhahn N, Ferretti E, Robbiani DF, Callen E, Deroubaix S, Selleri L, Nussenzweig A, Nussenzweig MC.
The hSSB1 orthologue Obfc2b is essential for skeletogenesis but dispensable for the DNA damage response in vivo.
EMBO J. 31: 4045-56, 2012. [Journal]
5)  Gapud EJ, Dorsett Y, Yin B, Callen E, Bredemeyer A, Mahowald GK, Omi KQ, Walker LM, Bednarski JJ, McKinnon PJ, Bassing CH, Nussenzweig A, Sleckman BP.
Ataxia telangiectasia mutated (Atm) and DNA-PKcs kinases have overlapping activities during chromosomal signal joint formation.
Proc. Natl. Acad. Sci. U.S.A. 108: 2022-7, 2011. [Journal]
6)  Castella M, Pujol R, Callén E, Ramírez MJ, Casado JA, Talavera M, Ferro T, Muñoz A, Sevilla J, Madero L, Cela E, Beléndez C, de Heredia CD, Olivé T, de Toledo JS, Badell I, Estella J, Dasí Á, Rodríguez-Villa A, Gómez P, Tapia M, Molinés A, Figuera Á, Bueren JA, Surrallés J.
Chromosome fragility in patients with Fanconi anaemia: diagnostic implications and clinical impact.
J. Med. Genet. 48: 242-50, 2011. [Journal]
7)  Zhang S, Yajima H, Huynh H, Zheng J, Callen E, Chen HT, Wong N, Bunting S, Lin YF, Li M, Lee KJ, Story M, Gapud E, Sleckman BP, Nussenzweig A, Zhang CC, Chen DJ, Chen BP.
Congenital bone marrow failure in DNA-PKcs mutant mice associated with deficiencies in DNA repair.
J. Cell Biol. 193: 295-305, 2011. [Journal]
8)  Castella M, Pujol R, Callén E, Trujillo JP, Casado JA, Gille H, Lach FP, Auerbach AD, Schindler D, Benítez J, Porto B, Ferro T, Muñoz A, Sevilla J, Madero L, Cela E, Beléndez C, de Heredia CD, Olivé T, de Toledo JS, Badell I, Torrent M, Estella J, Dasí A, Rodríguez-Villa A, Gómez P, Barbot J, Tapia M, Molinés A, Figuera A, Bueren JA, Surrallés J.
Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations.
Blood. 117: 3759-69, 2011. [Journal]
9)  Bothmer A, Robbiani DF, Di Virgilio M, Bunting SF, Klein IA, Feldhahn N, Barlow J, Chen HT, Bosque D, Callen E, Nussenzweig A, Nussenzweig MC.
Regulation of DNA end joining, resection, and immunoglobulin class switch recombination by 53BP1.
Mol. Cell. 42: 319-29, 2011. [Journal]
10)  Bunting SF, Callén E, Wong N, Chen HT, Polato F, Gunn A, Bothmer A, Feldhahn N, Fernandez-Capetillo O, Cao L, Xu X, Deng CX, Finkel T, Nussenzweig M, Stark JM, Nussenzweig A.
53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks.
Cell. 141: 243-54, 2010. [Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 5/13/2013.